Fresenius Medical Care (FMEA) Financial Statements
Fresenius Medical Care Financial Overview
Fresenius Medical Care's market cap is currently $10.73B. The company's EPS TTM is $1.67; its P/E ratio is 12.20; and it has a dividend yield of 3.66%. Fresenius Medical Care is estimated to report earnings on February 23, 2027, and the estimated EPS forecast is $0.55. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 19.63B | $ 19.34B | $ 19.45B | $ 19.40B | $ 17.62B |
| Gross Profit | $ 5.03B | $ 4.76B | $ 4.93B | $ 4.89B | $ 4.77B |
| Operating Income | $ 1.83B | $ 1.47B | $ 1.37B | $ 1.51B | $ 1.85B |
| EBITDA | $ 3.40B | $ 3.21B | $ 3.21B | $ 3.42B | $ 3.55B |
| Net Income | $ 978.37M | $ 537.91M | $ 499.00M | $ 673.40M | $ 969.31M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.60B | $ 1.34B | $ 1.56B | $ 1.46B | $ 1.64B |
| Total Assets | $ 31.00B | $ 33.57B | $ 33.93B | $ 35.75B | $ 34.37B |
| Total Debt | $ 10.79B | $ 11.00B | $ 12.08B | $ 13.21B | $ 13.32B |
| Net Debt | $ 9.20B | $ 9.82B | $ 10.67B | $ 11.94B | $ 11.84B |
| Total Liabilities | $ 16.72B | $ 17.80B | $ 19.10B | $ 20.30B | $ 20.39B |
| Stockholders' Equity | $ 14.28B | $ 14.58B | $ 13.62B | $ 13.99B | $ 12.70B |
| Cash Flow | |||||
| Free Cash Flow | $ 1.70B | $ 1.69B | $ 1.94B | $ 1.44B | $ 1.64B |
| Operating Cash Flow | $ 2.58B | $ 2.39B | $ 2.63B | $ 2.17B | $ 2.49B |
| Investing Cash Flow | $ -666.18M | $ -84.94M | $ -544.23M | $ -734.73M | $ -1.20B |
| Financing Cash Flow | $ -1.38B | $ -2.57B | $ -1.86B | $ -1.62B | $ -1.02B |
Currency in EUR
